Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-23-003493

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 51.01M sh
Capex Q1 2023 · Mar 31, 2023 $0
Capex Q1 2023 · Mar 31, 2022 $14K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $1.84M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $2.31M
Current Liabilities Q1 2023 · Mar 31, 2023 $4M
Current Liabilities Q1 2023 · Dec 31, 2022 $4.87M
Total Liabilities Q1 2023 · Mar 31, 2023 $5.75M
Total Liabilities Q1 2023 · Dec 31, 2022 $6.25M
Current Assets Q1 2023 · Mar 31, 2023 $2.55M
Current Assets Q1 2023 · Dec 31, 2022 $3M
Total Assets Q1 2023 · Mar 31, 2023 $2.89M
Total Assets Q1 2023 · Dec 31, 2022 $3.37M
Shares Diluted Q1 2023 · Mar 31, 2022 20.68M sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$179K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$4.99M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$5.45M
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.05
Eps Basic Q1 2023 · Mar 31, 2022 −$0.05
Sga Expense Q1 2023 · Mar 31, 2022 $386K
Rd Expense Q1 2023 · Mar 31, 2022 $21K
Net Income Q1 2023 · Mar 31, 2022 −$507K
Operating Income Q1 2023 · Mar 31, 2022 −$443K
Gross Profit Q1 2023 · Mar 31, 2022 $4K
Revenue Q1 2023 · Mar 31, 2022 $5K